Certificate PL-26-00205 · Gonadorelin 2 mg · lot PL-2610-087 · branded for Epic Wholesalers LLC -dba-Epic Peptides Lab
VerifyCertificate page
Epic Wholesalers LLC -dba-Epic Peptides Lab
Epic Wholesalers LLC -dba-Epic Peptides Lab
Certificate of Analysis · Lot release
www.epicpeptideslab.com
Certificate no.
PL-26-00205
Verification key
JHYKC54Y
Scan or enter both at
prymalab.net/testing/verify

Certificate of Analysis · Lot release · Issued for Epic Wholesalers LLC -dba-Epic Peptides Lab

Gonadorelin 2 mg

Lot PL-2610-087 · Lyophilized powder · Label claim 2 mg per vial
Tested in-house by PrymaLab
In-house analytical result,
not an independent third-party test
Lot / batch number
PL-2610-087
Date made
2026-10-02
Date of analysis
2026-10-05
Date issued
2026-10-20
Retest / expiry
2028-10-02
Units in lot / sampled
293 / 2
Storage
−20 °C, desiccated, dark
Certificate type
Lot COA, 2 pages
Compound
Gonadorelin
Native gonadotropin-releasing hormone (GnRH, LHRH)
CAS number
33515-09-2
Molecular formula
C55H75N17O13
Theoretical mass (avg.)
1,182.30 Da
Sequence
pEHWSYGLRPG-NH2
Purity · RP-HPLC, area %
99.78%
Specification ≥ 99.0% • main peak at 12.38 min
Identity · Observed Mass
1,182.23 Da
Theoretical 1,182.30 Da • −0.07 Da (59 ppm)
Overall conclusion
PASS
Meets every specification for the tests performed
TestMethodSpecificationResultConclusion
Identity (mass)LC-MS, ESI positiveTheoretical ± 1.0 Da1,182.23 DaPASS
PurityRP-HPLC, UV 214 nm, area%≥ 99.0%99.78%PASS
Largest impurityRP-HPLC, area%≤ 1.0%0.09% (RT 13.60)PASS
Water contentKarl Fischer≤ 5.0%1.74%PASS
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.098 EU/mgPASS
SterilityUSP <71>, 14-dayNo growthNo growthPASS

1HPLC chromatogram

Data file: PL-2610-087-HPLC.raw · Column C18, 150 × 4.6 mm · UV 214 nm
0.01%0.1%1%10%100%101112131415Retention time (min) · stick height = area % (log scale)99.78% · 12.38 min0.05% †0.08% †0.09% †
Peak plot drawn from the integrated peak table (area %, log scale); it is not the instrument trace, which is retained in PL-2610-087-HPLC.raw. † Nominal reference retention time for the assigned impurity; the main-peak RT is observed in this lot.
Epic Wholesalers LLC -dba-Epic Peptides Lab
Epic Wholesalers LLC -dba-Epic Peptides Lab
Certificate of Analysis · continued
Gonadorelin 2 mg · Lot PL-2610-087 · Certificate PL-26-00205
Lot PL-2610-087
Method, peak table and approval

2HPLC method · PL-2610-087-HPLC.raw

Instrument
Waters Alliance e2695
Data System
Empower 3
Detector
UV absorbance
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Gradient
5–95% B over 25 min (linear)
Flow Rate
1.0 mL/min
Column Temperature
40 °C
Injection Volume
10 µL

3Gradient program

Time (min)% A% B
0.0955
25.0595

4Peak table

PeakRT (min)AreaArea %
111.20 †—0.05
212.38—99.78
312.90 †—0.08
413.60 †—0.09
Total—100.00
Peaks: 1 deamidation product; 2 main peak (Gonadorelin); 3 tryptophan oxidation product; 4 truncated sequence · Area % from the integrated peak table (absolute areas are not part of the lot-release export) · † nominal reference RT for the assigned impurity · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.

5Identity by mass spectrometry

Instrument
Waters SQD
Ionization / Mode
ESI, positive
Reference m/z (charge)
592.16 (2+) · 395.11 (3+)
Deconvoluted Mass
1,182.23 Da
Theoretical Mass
1,182.30 Da
Difference
−0.07 Da (59 ppm)
Data File
PL-2610-087-MS.d
Acceptance
Within ± 1.0 Da

6Additional tests

TestPerformed byDateReport / file
Water content (Karl Fischer)PrymaLab Analytical2026-10-05—
Endotoxin (LAL, kinetic)PrymaLab Analytical2026-10-05—
Sterility (USP <71>, day-14 read-out)PrymaLab Analytical2026-10-19—
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.

7Review and approval

D. Reynolds
Analyst · performed the testing
Date: 2026-10-20
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-20
M. Phelps
Lab Director · approved for release
Date: 2026-10-20